Physiology of the prostateFRICK, J; AULITZKY, W.Infection. 1991, Vol 19, pp S115-S118, issn 0300-8126, SUP3Conference Paper

Clinical applications of cytokinesPESCHEL, C; HUBER, C; AULITZKY, W. E et al.La Presse médicale (1983). 1994, Vol 23, Num 23, pp 1083-1091, issn 0755-4982Article

Increasing infertility in myotonia dystrophica curschmann-steinertHAUSER, W; AULITZKY, W; BALTACI, S et al.European urology. 1991, Vol 20, Num 4, pp 341-342, issn 0302-2838Article

Pulsatile LHRH therapy in patients with oligozoospermia and disturbed LH pulsatilityAULITZKY, W; FRICK, J; HADZISELIMOVIC, F et al.International journal of andrology (Print). 1989, Vol 12, Num 4V, pp 265-272, issn 0105-6263Article

Cytokine therapy of neoplastic and inflammatory diseaseAULITZKY, W. E; HUBER, C; PESCHEL, C et al.International archives of allergy and immunology. 1993, Vol 101, Num 3, pp 221-226, issn 1018-2438Article

Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadismAULITZKY, W; FRICK, J; GALVAN, G et al.Fertility and sterility. 1988, Vol 50, Num 3, pp 480-486, issn 0015-0282Article

Evaluation des troubles de la fertilité et traitement chez l'homme par administration chronique intermittente de LH-RH = Evaluation and treatment of infertile men by chronic intermittent (pulsatile) administration of LH-RHAULITZKY, W; FRICK, J; JOOS, H et al.Contraception fertilité sexualité (1973). 1985, Vol 13, Num 7-8, pp 913-915, issn 0301-861XArticle

Treatment of cancer patients with recombinant interferon-γ induces release of endogenous tumor necrosis factor-αAULITZKY, W. E; AULITZKY, W. K; FRICK, J et al.Immunobiology (1979). 1990, Vol 180, Num 4-5, pp 385-394, issn 0171-2985, 10 p.Article

Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2AULITZKY, W. E; TILG, H; VOGEL, W et al.Annals of hematology (Print). 1991, Vol 62, Num 1, pp 25-31, issn 0939-5555, 7 p.Article

Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ)AULITZKY, W. E; GROSSE-WILDE, H; WESTHOFF, U et al.Clinical and experimental immunology (Print). 1991, Vol 86, Num 2, pp 236-239, issn 0009-9104Article

Tissue polypeptide-specific antigen in renal cell carcinoma. CommentaryHÖBARTH, K; HALLAS, A; KRAMER, G et al.European urology. 1996, Vol 30, Num 1, pp 89-95, issn 0302-2838Article

Effect of high energy shock waves on human spermatozoa in vitroKALLA, N. R; AULITZKY, W; WASTIAN, S et al.European urology. 1988, Vol 14, Num 3, pp 240-242, issn 0302-2838Article

Health care delivery systems in western Europe, eastern Europe, and the United States: a forum among practicing cardiologists from 16 countriesSCHEIDT, S; AULITZKY, W; CHELUTKIENE, J et al.Cardiovascular reviews & reports. 1995, Vol 16, Num 7, pp 34-56, issn 0197-3118, 19 p.Article

Cytokines in the control of beta-2 microglobulin release.II: In vivo studies with recombinant interferons and antigensNACHBAUR, K; TROPPMAIR, J; KOTLAN, B et al.Immunobiology (1979). 1988, Vol 177, Num 1, pp 66-75, issn 0171-2985Article

Treatment of havy-cell leukemia with recombinant alpha₂-interferonBERNEMAN, Z. N; GASTL, G; GANGJI, D et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 8, pp 987-990, issn 0277-5379Article

Interferon-γ for the treatement of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responsesAULITZKY, W; GASTL, G; AULITZKY, W. E et al.Immunobiology (1979). 1987, Vol 176, Num 1-2, pp 85-95, issn 0171-2985Article

Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLFISCHER, T; NEUBAUER, A; DUYSTER, J et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 10, pp 1029-1036, issn 0268-3369Article

Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia : results of a phase-II trialSCHNELLER, F; SCHULER, M; SCHUMACHER, K et al.Annals of hematology (Print). 1998, Vol 77, Num 5, pp 225-229, issn 0939-5555Article

Low-dose γ-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burdenAULITZKY, W. E; LERCHE, J; HUBER, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 7, pp 940-945Article

Recombinant interferon-alpha-2C in chronic myelogenous leukaemia : relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical responseGEISSLER, D; GASTL, G; AULITZKY, W et al.Leukemia research. 1990, Vol 14, Num 7, pp 629-636, issn 0145-2126, 8 p.Article

Endogenous IFN-gamma during human bone marrow transplantation : analysis of serum levels of interferon and interferon-dependent secondary messagesNIEDERWIESER, D; HEROLD, M; WOLOSZCZUK, W et al.Transplantation. 1990, Vol 50, Num 4, pp 620-625, issn 0041-1337, 6 p.Article

Bioassay for determination of human serum Luteinizing hormone (H): a routine clinical methodSTADLER, U; ROVAN, E; AULITZKY, W et al.Andrologia. 1989, Vol 21, Num 6, pp 580-583, issn 0303-4569Article

A biological approach to optimize interferon treatment in hairy cell leukemiaGASTL, G; AULITZKY, W; TILG, H et al.Immunobiology (1979). 1986, Vol 172, Num 3-4-5, pp 262-268, issn 0171-2985Article

Recombinant α2 interferon for induction and maintenance of remission in hairy cell leukaemiaGASTL, G; AULITZKY, W; MARGREITER, R et al.British journal of haematology. 1985, Vol 61, Num 3, pp 581-582, issn 0007-1048Article

Interleukins : clinical pharmacology and therapeutic useAULITZKY, W. E; SCHULER, M; PESCHEL, C et al.Drugs (Basel). 1994, Vol 48, Num 5, pp 667-677, issn 0012-6667Article